Preoperative b-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 5, 2011, Pages 778-783

  Ganem, Fernando ^a   Serrano, Carlos V ^a   Fernandes, Juliano L ^a   Blotta, Maria Heloísa S L ^b   Souza, Juliana A ^a   Nicolau, José C ^a   Ramires, José A F ^a   Hueb, Whady A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Brain natriuretic peptide; Heart surgery; Inflammation markers; Ischemic cardiomyopathy

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DOBUTAMINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; PADGEM PROTEIN;

ACCURACY; ADULT; ADVERSE OUTCOME; ANEURYSM SURGERY; AREA UNDER THE CURVE; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREDICTION; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 79956205869     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.255257     Document Type: Article

References (25)

1. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: a clinical severity score. J Am Med Assoc 1992;267:2344-2348.
2. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989;79:3-12.
3. Maeda K, Tsutamoto T, Wada A, Hisnaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-832.
4. Tang WH, Francis GS, Morrow DA, Newby LK, Cannon CP, Jesse RL, Storrow AB, Christenson RH, Apple FS, Ravkilde J, Wu AH. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007;116:99-109.
5. ten Wolde M, Tulevski II, Mulder JW, Söhne M, Boomsma F, Mulder BJ, Büller HR. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 2003;107:2082-2084.
6. Charpentier J, Luyt C, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche JD. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004;32:660-665.
7. Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation 1997;95:778-781.
8. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
9. Hueb W, Soares PR, Gersh BJ, Cesar LA, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JA. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 2004;43:1743-1751.
10. Turk T, Ata Y, Ay D, Ozkan H, Vural H, Yavuz S, Ozyazicioglu A. Plasma brain natriuretic peptide after isolated on-pump coronary artery bypass grafting: prediction of postoperative adverse outcomes. Heart Surg Forum 2008;11:E84-E89.
11. Fransen E, Maessen J, Elenbaas T, van Aarnhem E, van Dieijen-Visser M. Enhanced preoperative c-reactive protein plasma levels as a risk for postoperative infections after cardiac surgery. Ann Thorac Surg 1999; 67:134-138.
12. Biancari F, Lahtinen J, Lepojärvi S, Rainio P, Salmela E, Pokela R, Lepojärvi M, Satta J, Juvonen TS. Preoperative C-reactive protein and outcome after coronary artery bypass surgery. Ann Thorac Surg 2003; 76:2007-2012.
13. Gaudino M, Nasso G, Andreotti F, Minniti, Iacoviello L, Donati M, Schiavello R, Possati G. Preoperative C-reactive protein level, and outcome following coronary surgery. Eur J Cardiothorac Surg 2002; 22:521-526.
14. Hansson GK. Inflammation, atherosclerosis, and coronary disease. N Engl J Med 2005;352:1685-1695.
15. Wan S, Le Clerc J-L, Vincent J-L. Inflammatory response to CPB. Chest 1997;112:676-692.
16. Serrano CV, Souza JA, Lopes NH, Fernandes JL, Nicolau JC, Blotta MHSL, Ramires JAF, Hueb WA. Reduced expression of systemic proinflammatory and myocardial biomarkers after off-pump versus on-pump coronary artery bypass surgery. J Crit Care 2009;25:305-312.
17. Ascione R, Loyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 2000;69:1198-1204.
18. Maisel A. B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin 2001;19:557-571.
19. Cuthbertson BH, Card G, Croal Bl, McNeilly J, Hillis GS. The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major non-cardiac surgery. Anesthesia 2007;62:875-881.
20. Gibson SC, Payne CJ, Byrne DS, Berry C, Dargie HJ, Kingsmore DB. Btype natriuretic peptide predicts cardiac morbidity and mortality after major surgery. Br J Surg 2007;94:903-909.
21. Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James RN, Chiu A, Maisel AS. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004;43:1873-1879.
22. Attaran S, Sherwood R, Desai J, Langworthy R, Mhandu P, Lindsay J, El Gamel A. Brain natriuretic peptide a predictive marker in cardiac surgery. Interact CardioVasc Thorac Surg 2009;9:662-666.
23. Wazny OM, Martin DO, Marrouche NF, Latif AA, Ziada K, Shaaraoui M, Almahameed S, Scweikert RA, Saliba WI, Gillinov AM, Tang WH, Mills RM, Francis GS, Young JB, Natale A. Plasma B-type natriuretic peptide levels predict atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004;110:124-127.
24. Eliasdottir SB, Klemenzson G, Torfason B, Valsson F. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiol Scand 2008;52:182-187.
25. Jogia PM, Kalkoff M, Sleigh JW, Bertinelli A, La Pine M, Richards AM, Devlin G. NT-pro BNP secretion and clinical endpoints in cardiac surgery intensive care patients. Anaesth Intensive Care 2007;35:363-369.